Litigation

Recent Posts

Glaxo Adds Safety Restrictions To Avandia Label
Posted on 9 Feb 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration... Read More

A Word Change Here And There and Voila! GlaxoSmithKline Has Itself 33 New Avandia Experts
Posted on 17 Aug 2010 by Tom Moylan

So you saw the words "$2.36 billion," "settlement," and "Avandia" used in the same sentence and you think the litigation is over? Well, the old gal's still kicking and nowhere was that more apparent that in GSK's... Read More

Most FDA Advisers Recommend Avandia Stay On The Market
Posted on 14 Jul 2010 by Tom Moylan

GAITHERSBURG, Md. - (Mealey's) A majority of Food and Drug Administration advisers voted July 14 to keep Avandia on the market but split on whether the anti-diabetes drug made by GlaxoSmithKline PLC (GSK) should carry additional warnings about its... Read More

2 Attorneys Settle Their Avandia Cases In Federal, State Courts
Posted on 10 May 2010 by Tom Moylan

PHILADELPHIA — (Mealey’s) Two attorneys have settled their Avandia personal injury cases in federal and state courts with defendant GlaxoSmithKline plc, a source told Mealey Publications May 10. According to the source, W. Mark Lanier of... Read More